106 related articles for article (PubMed ID: 1439070)
21. [The efficacy of 2 new drug forms of isosorbide-5-mononitrate in patients with stable stenocardia of effort].
Metelitsa VI; Martsevich SIu; Kutishenko NP; Kozyreva MP; Blagodatskikh SV; Simkhaev LS; Slastnikova ID; Vakulovskaia MK
Ter Arkh; 1994; 66(8):22-5. PubMed ID: 7985147
[No Abstract] [Full Text] [Related]
22. Effects of 8:00 a.m. and 2:00 p.m. doses of isosorbide-5-mononitrate during twice-daily therapy in stable angina pectoris.
Thadani U; Bittar N
Am J Cardiol; 1992 Aug; 70(3):286-92. PubMed ID: 1632390
[TBL] [Abstract][Full Text] [Related]
23. [A new anti-ischemic drug for the treatment of stable effort angina pectoris: nicorandil. Comparison with placebo and isosorbide-5-mononitrate].
Lai C; Onnis E; Solinas R; Orani E; Lai G; Cadeddu M; Cherchi A
Cardiologia; 1991 Sep; 36(9):703-11. PubMed ID: 1839369
[TBL] [Abstract][Full Text] [Related]
24. Randomized crossover trial of isosorbide mononitrate (Elantan 20) and slow-release glyceryl trinitrate in the treatment of angina pectoris.
Brodie NH; O'Hara H; O'Hara J; Valle-Jones JC
Pharmatherapeutica; 1985; 4(6):367-75. PubMed ID: 3936056
[TBL] [Abstract][Full Text] [Related]
25. Isosorbide 5-mononitrate: a review of a sustained-release formulation (Imdur) in stable angina pectoris.
Gunasekara NS; Noble S
Drugs; 1999 Feb; 57(2):261-77. PubMed ID: 10188765
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the antianginal effect of isosorbide-5-mononitrate in patients with chronic stable angina pectoris.
Yasky J; Ontanilla E; Koch JE
Cardiology; 1991; 79 Suppl 2():27-30. PubMed ID: 1760826
[TBL] [Abstract][Full Text] [Related]
27. A double-blind, parallel-group study of amlodipine versus long-acting nitrate in the management of elderly patients with stable angina.
Hall R; Chong C
Cardiology; 2001; 96(2):72-7. PubMed ID: 11740135
[TBL] [Abstract][Full Text] [Related]
28. Anti-anginal and anti-ischemic efficacy of conventional and slow release formulations of isosorbide-5-mononitrate in angina pectoris.
Thadani U
Z Kardiol; 1985; 74 Suppl 4():21-4. PubMed ID: 4096067
[TBL] [Abstract][Full Text] [Related]
29. Eccentric dosing with isosorbide-5-mononitrate in angina pectoris.
Parker JO
Am J Cardiol; 1993 Oct; 72(12):871-6. PubMed ID: 8213541
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of controlled-release isosorbide-5-mononitrate in Japanese patients with stable effort angina pectoris.
Shimada K; Sunayama S; Nakazato K; Satoh H; Kusama Y; Kawakubo K; Daida H
Int Heart J; 2006 Sep; 47(5):695-705. PubMed ID: 17106140
[TBL] [Abstract][Full Text] [Related]
31. The effect of isosorbide-5-mononitrate (5-ISMN) Durules on exercise tolerance in patients with exertional angina pectoris. A placebo controlled study.
Nyberg G; Carlens P; Lindström E; Lundman T; Nordlander R; Rehnqvist N; Ulvenstam G; Aberg A; Aström H
Eur Heart J; 1986 Oct; 7(10):835-42. PubMed ID: 3539613
[TBL] [Abstract][Full Text] [Related]
32. [4 different nitrate preparations with regard to the possible development of tolerance in long-term treatment].
Mertens HM; Ohlmeier H; Mannebach H; Kabelitz K; Gleichmann U
Herz; 1985 Jun; 10(3):172-81. PubMed ID: 3926614
[TBL] [Abstract][Full Text] [Related]
33. Comparison of efficacy of nisoldipine, metoprolol, and isosorbide dinitrate in patients with stable exertional angina: a randomized, cross-over, placebo-controlled study.
Ogawa H; Yasue H; Nakamura N; Fujii H; Miyagi H; Kikuta K
Int J Cardiol; 1995 Feb; 48(2):131-7. PubMed ID: 7774991
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of eccentric dosing with sustained-release isosorbide dinitrate in patients with angina pectoris.
Parker JO; Baird MG
Can J Cardiol; 1994 Nov; 10(9):909-12. PubMed ID: 7954026
[TBL] [Abstract][Full Text] [Related]
35. Lack of tolerance after chronic administration of controlled-release isosorbide-5-mononitrate. Interaction of nitrate and gallopamil.
Stauch M; Grossmann G; Wanjura D; Adam WE
Eur J Clin Pharmacol; 1990; 38 Suppl 1():S31-4. PubMed ID: 2354712
[TBL] [Abstract][Full Text] [Related]
36. [Intraindividual dose-response relationship of sustained-release Elantan].
Kenedi P
Z Kardiol; 1986; 75 Suppl 3():77-9. PubMed ID: 3541420
[TBL] [Abstract][Full Text] [Related]
37. Acute and chronic effects of once-daily isosorbide-5-mononitrate on the exercise capacity of patients with angina pectoris treated with a beta-blocking drug.
Eteiba H; Hutton I; Foale RA; Akhras F; Jackson G; Prescott RJ; Hallam RJ; Quinn KJ
Br J Clin Pract; 1991; 45(3):185-8. PubMed ID: 1687200
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of a single dose of slow-release isosorbide dinitrate in the treatment of silent or painful myocardial ischemia in stable angina pectoris.
Dubiel JP; Moczurad KW; Bryniarski L
Am J Cardiol; 1992 May; 69(14):1156-60. PubMed ID: 1575184
[TBL] [Abstract][Full Text] [Related]
39. [The acute and chronic effects of 50 mg of isosorbide 5-mononitrate with delayed action in patients with stable angina of effort].
San José Garagarza J; Ruano Calvo J; Vázquez de Prada JA; Colman Dejean T; López Somoza C; Pajarón López A
Rev Esp Cardiol; 1992 Feb; 45(2):103-10. PubMed ID: 1561466
[TBL] [Abstract][Full Text] [Related]
40. Combined gallopamil and isosorbide-5-mononitrate in "mixed" angina pectoris.
Carboni GP; Saltarocchi ML; Risa AL; Scardovi AB; Zanchi E; Prati PL
J Cardiovasc Pharmacol; 1992; 20 Suppl 7():S64-70. PubMed ID: 1284159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
